dc.contributor.author | Selçuk, Nalan | |
dc.contributor.author | Ocak, Meltem | |
dc.contributor.author | Aygün, Aslan | |
dc.contributor.author | KANMAZ, MUSTAFA BEDİİ | |
dc.contributor.author | KABASAKAL, LEVENT | |
dc.contributor.author | Yeyin, Nami | |
dc.contributor.author | Demirci, Emre | |
dc.contributor.author | Toklu, Turkay | |
dc.date.accessioned | 2021-03-04T10:28:07Z | |
dc.date.available | 2021-03-04T10:28:07Z | |
dc.identifier.citation | Yeyin N., Demirci E., Toklu T., KABASAKAL L., Aygün A., Ocak M., Selçuk N., KANMAZ M. B. , "177Lu-[DOTA0,Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors", 25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2013, ss.306 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_6d594804-848f-4755-b568-43c3bfea69f8 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/75535 | |
dc.identifier.uri | http://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=4&SID=P2Pw8p4jxJEYZ8EPNkr&page=1&doc=19&cacheurlFromRightClick=no | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.title | 177Lu-[DOTA0,Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.contributor.firstauthorID | 645675 | |